06-07-21Merck Tests Molnupiravir, an Investigational Product, at the Lung Center of the Philippines While Large Ivermectin Trial Runs in Parallel [Merck formerly developed a version of Ivermectin, but it is now off-patent and there is no profit in it now.] The Philippines recently announced a large national ivermectin trial targeting early-onset COVID-19 https://trialsitenews.com/merck-tests-molnupiravir-an-investigational-product-at-the-lung-center-of-the-philippines-while-large-ivermectin-trial-runs-in-parallel/

06-08-21News Roundup | Mumbai Move for Ivermectin Prophylaxis While Uttar Pradesh Smashes COVID-19 Three Indian states, including Goa, Karnataka and Uttarakhand, have authorized ivermectin as a prophylaxis along with vitamin D during the pandemic. With ivermectin now on the national Indian COVID-19 list of recommended treatments for COVID-19, a few states have gone to the next level and included the low-cost, generic drug approved throughout the world as a parasite fighter as a prophylactic targeting SARS-CoV-2, the virus behind COVID-19. https://trialsitenews.com/news-roundup-mumbai-move-for-ivermectin-prophylaxis-while-uttar-pradesh-smashes-covid-19/
And also: https://www.thedesertreview.com/news/national/ivermectin-obliterates-97-percent-of-delhi-cases/article_6a3be6b2-c31f-11eb-836d-2722d2325a08.html

06-09-21Indonesian Researchers Conduct Meta-Analysis of Ivermectin & Find Compelling Efficacy Targeting COVID-19 The researchers reviewed 19 studies with 2,768 COVID-19 patients in the study. They found that ivermectin was associated with a reduction in the severity of COVID-19, reduction of mortality, higher negative RT-PCR test result rate, shorter time to negative RT-PCR test results, higher rate of reducing COVID symptoms, and shorter hospitalization duration as measured by time to discharge. Yet another comprehensive meta-analysis suggests ivermectin could offer beneficial effects when treating COVID-19. https://trialsitenews.com/indonesian-researchers-conduct-meta-analysis-of-ivermectin-find-compelling-efficacy-targeting-covid-19/

06-10-21CATalyst | Indian Bar Association Serves Legal Notice on WHO’s chief scientist Dr. Soumya Swaminathan The Indian Bar Association’s decision to issue legal notice on WHO chief scientist, Dr Soumya Swaminathan. The 51-page notice, served 25th of May, claims as its legal basis the WHO’s ‘disinformation and censorship’ on the Ivermectin issue. https://trialsitenews.com/catalyst-indian-bar-association-serves-legal-notice-on-whos-chief-scientist-dr-soumya-swaminathan/

06-11-21The Truth About Ivermectin The truth about the censorship and suppression of data about the efficacy of Ivermectin in the treatment of COVID-19 https://odysee.com/@DeceptionAndLies:f/The-Ivermectin-Story:b

06-15-21South Valley University in Egypt’s Clinical Trial Reveals Ivermectin-based Nasal Spray Improves COVID-19 Outcomes Based on the study results, the investigators concluded that the local use of ivermectin mucoadhesive nanosuspension nasal spray is safe and effective in the treatment of mild COVID-19 patients with rapid viral clearance and recovery of respiratory manifestations (anosmia, cough, and dyspnea). https://trialsitenews.com/south-valley-university-in-egypts-clinical-trial-reveals-ivermectin-based-nasal-spray-improves-covid-19-outcomes/

06-21-21Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines PMID: 34145166 https://pubmed.ncbi.nlm.nih.gov/34145166/ And: https://journals.lww.com/americantherapeutics/fulltext/2021/08000/ivermectin_for_prevention_and_treatment_of.7.aspx Repurposed medicines may have a role against the SARS-CoV-2 virus. The antiparasitic ivermectin, with antiviral and anti-inflammatory properties, has now been tested in numerous clinical trials. Meta-analysis of 15 trials found that ivermectin reduced risk of death compared with no ivermectin. Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally. 06-22-21Bavarian Television Highlights Successful Use of Ivermectin The chief doctor and anesthesiologist in intensive care, Dr. Franz Brettner at the academic medical center known as the Barmherzige Bruder Hospital in Munich, affiliated with the University of Munich and the German Academy for Nutritional Medicine, reports that the use of ivermectin targeting COVID-19 has made a material difference in the lives of patients. https://trialsitenews.com/bavarian-television-highlights-successful-use-of-ivermectin/

06-23-21Malaysian Activist Group Files Criminal Report Against Minister of Health for Keeping Ivermectin from the People A consumer rights group in the Southeastern Asian nation of Malaysia filed a police report targeting the Health Ministry for failing to use ivermectin to prevent COVID-19. In an unprecedented action, the Malaysia Muslim Consumers Association (PPIM) issued a statement declaring, “The Health Ministry’s refusal to consider the effectiveness of Ivermectin is a criminal offense as that has caused more than 2,300 COVID-19 patients to die.” https://trialsitenews.com/malaysian-activist-group-files-criminal-report-against-minister-of-health-for-keeping-ivermectin-from-the-people/

06-23-21News Roundup | UK-based Meta Analysis On Ivermectin Peer Reviewed & Published UK-based Meta Analysis Peer Reviewed & Published Suggests Ivermectin A Key Public Health Weapon in the War Against COVID-19 Recently published in the peer-reviewed American Journal of Therapeutics, Dr. Tess Lawrie, an expert in medicinal evidence, along with other experts in population health and gastroenterology out of the United Kingdom (UK), conducted a comprehensive meta-analysis involving the certainty of evidence using an approach known as GRADE, which led to the focus on twenty-four ivermectin-centered randomized controlled trials involving 3,406 participants. https://trialsitenews.com/news-roundup-uk-based-meta-analysis-on-ivermectin-peer-reviewed-published/

06-23-21University of Oxford PRINCIPLE Study Now Includes Ivermectin
https://trialsitenews.com/university-of-oxford-principle-study-now-includes-ivermectin/

06-23-21Ivermectin for COVID-19: real-time meta analysis of 60 studies NOTE: There have been 60 completed Ivermectin studies (and numerous more are in progress) evidencing sufficient safety and efficacy. To date, these 60 studies involved: 18,931 patients and 549 investigators/scientists and represent stunning results.
85% improvement across 14 prophylaxis studies; 76% improvement in 25 early treatment trials; and 46% improvement in 21 late treatment trials along with 70% improvement in 22 mortality results. Of 31 randomized controlled trials: 64% show improvement. In addition, a prominent meta-analysis from the UK, published in the peer-review American Journal of Therapeutics, reveals that across 3,406 COVID-19 patients, Ivermectin led to a reduced risk of death, lowered infection, and even prophylactic benefits. https://ivmmeta.com/

06-24-21Ivermectin Authorized in Indonesia as Pharma Issued License for Production to Battle COVID-19 The country’s national drug regulator authorized the use of ivermectin on an off-label basis targeting COVID-19. Based on the results of a study, … production now has commenced with plans for distribution of over 4 million units per month, declaring formally that ivermectin is now authorized as a therapy for COVID-19. https://trialsitenews.com/ivermectin-authorized-in-indonesia-as-pharma-issued-license-for-production-to-battle-covid-19/

07-08-21NIH approves IVERMECTIN for use in treatment of COVID-19 – 78 studies in progress or completed showing efficacy https://www.covid19treatmentguidelines.nih.gov/tables/table-2e/

07-24-21International Coalition of Medical Experts Tout the Effectiveness of IVERMECTIN https://www.theepochtimes.com/doctors-raise-awareness-on-ivermectin-as-treatment-for-covid-19-to-help-end-the-pandemic_3916366.html In an effort to help end the pandemic, an international coalition of medical experts held “World Ivermectin Day” to raise awareness about the effectiveness of ivermectin as a treatment for COVID-19.

07-28-21Ivermectin for preventing and treating COVID-19 https://pubmed.ncbi.nlm.nih.gov/34318930/ Ivermectin, an antiparasitic agent used to treat parasitic infestations, inhibits the replication of viruses in vitro. The molecular hypothesis of ivermectin's antiviral mode of action suggests an inhibitory effect on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication in the early stages of infection.

07-31-21White paper on Ivermectin as a potential therapy for COVID-19 https://pubmed.ncbi.nlm.nih.gov/32825892/ After critical panel discussion, all the attending doctors came to a conclusion that Ivermectin can be a potential molecule for prophylaxis and treatment of people infected with Coronavirus, owing to its anti-viral properties coupled with effective cost, availability and good tolerability and safety.

08-11-21Potential use of ivermectin for the treatment and prophylaxis of SARS-CoV-2 infection https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354804/ “…Recently, promising results of several studies on oral ivermectin have been published, which has prompted us to conduct the present review of the scientific literature. The reviewed literature suggests that there seems to be sufficient evidence about the safety of oral ivermectin, as well as the efficacy of the drug in the early-treatment and the prophylaxis of COVID-19.”

09-17-21 El Salvador Minister of Public Health Includes Ivermectin as COVID-19 Pandemic Continues https://trialsitenews.com/el-salvador-minister-of-public-health-includes-ivermectin-as-covid-19-pandemic-continues/ El Salvador’s Ministry of Public Health (Ministerio de Salud Publica—MINSAL) embraced the anti-parasitic drug ivermectin as part of a combination of recommendations for early-onset treatment of COVID-19 via an ambulatory home patient kit which included vitamins and other therapeutics.

Ongoing trials - https://clinicaltrials.gov/

72 Studies found for: Ivermectin | Covid

23 Studies for Ivermectin | SARS-CoV-2

186 Studies for Ivermectin | entire Database

06-07-21 Merck Tests Molnupiravir, an Investigational Product, at the Lung Center of the Philippines While Large Ivermectin Trial Runs in Parallel [Merck formerly developed a version of Ivermectin, but it is now off-patent and there is no profit in it now.] The Philippines recently announced a large national ivermectin trial targeting early-onset COVID-19 https://trialsitenews.com/merck-tests-molnupiravir-an-investigational-product-at-the-lung-center-of-the-philippines-while-large-ivermectin-trial-runs-in-parallel/

06-08-21 News Roundup | Mumbai Move for Ivermectin Prophylaxis While Uttar Pradesh Smashes COVID-19 Three Indian states, including Goa, Karnataka and Uttarakhand, have authorized ivermectin as a prophylaxis along with vitamin D during the pandemic. With ivermectin now on the national Indian COVID-19 list of recommended treatments for COVID-19, a few states have gone to the next level and included the low-cost, generic drug approved throughout the world as a parasite fighter as a prophylactic targeting SARS-CoV-2, the virus behind COVID-19. https://trialsitenews.com/news-roundup-mumbai-move-for-ivermectin-prophylaxis-while-uttar-pradesh-smashes-covid-19/
And also: https://www.thedesertreview.com/news/national/ivermectin-obliterates-97-percent-of-delhi-cases/article_6a3be6b2-c31f-11eb-836d-2722d2325a08.html

06-09-21 Indonesian Researchers Conduct Meta-Analysis of Ivermectin & Find Compelling Efficacy Targeting COVID-19 The researchers reviewed 19 studies with 2,768 COVID-19 patients in the study. They found that ivermectin was associated with a reduction in the severity of COVID-19, reduction of mortality, higher negative RT-PCR test result rate, shorter time to negative RT-PCR test results, higher rate of reducing COVID symptoms, and shorter hospitalization duration as measured by time to discharge. Yet another comprehensive meta-analysis suggests ivermectin could offer beneficial effects when treating COVID-19. https://trialsitenews.com/indonesian-researchers-conduct-meta-analysis-of-ivermectin-find-compelling-efficacy-targeting-covid-19/

06-10-21 CATalyst | Indian Bar Association Serves Legal Notice on WHO’s chief scientist Dr. Soumya Swaminathan The Indian Bar Association’s decision to issue legal notice on WHO chief scientist, Dr Soumya Swaminathan. The 51-page notice, served 25th of May, claims as its legal basis the WHO’s ‘disinformation and censorship’ on the Ivermectin issue. https://trialsitenews.com/catalyst-indian-bar-association-serves-legal-notice-on-whos-chief-scientist-dr-soumya-swaminathan/

06-11-21 The Truth About Ivermectin The truth about the censorship and suppression of data about the efficacy of Ivermectin in the treatment of COVID-19 https://odysee.com/@DeceptionAndLies:f/The-Ivermectin-Story:b

06-15-21 South Valley University in Egypt’s Clinical Trial Reveals Ivermectin-based Nasal Spray Improves COVID-19 Outcomes Based on the study results, the investigators concluded that the local use of ivermectin mucoadhesive nanosuspension nasal spray is safe and effective in the treatment of mild COVID-19 patients with rapid viral clearance and recovery of respiratory manifestations (anosmia, cough, and dyspnea). https://trialsitenews.com/south-valley-university-in-egypts-clinical-trial-reveals-ivermectin-based-nasal-spray-improves-covid-19-outcomes/

06-21-21 Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines PMID: 34145166 https://pubmed.ncbi.nlm.nih.gov/34145166/ And: https://journals.lww.com/americantherapeutics/fulltext/2021/08000/ivermectin_for_prevention_and_treatment_of.7.aspx Repurposed medicines may have a role against the SARS-CoV-2 virus. The antiparasitic ivermectin, with antiviral and anti-inflammatory properties, has now been tested in numerous clinical trials. Meta-analysis of 15 trials found that ivermectin reduced risk of death compared with no ivermectin. Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally. 06-22-21 Bavarian Television Highlights Successful Use of Ivermectin The chief doctor and anesthesiologist in intensive care, Dr. Franz Brettner at the academic medical center known as the Barmherzige Bruder Hospital in Munich, affiliated with the University of Munich and the German Academy for Nutritional Medicine, reports that the use of ivermectin targeting COVID-19 has made a material difference in the lives of patients. https://trialsitenews.com/bavarian-television-highlights-successful-use-of-ivermectin/

06-23-21 Malaysian Activist Group Files Criminal Report Against Minister of Health for Keeping Ivermectin from the People A consumer rights group in the Southeastern Asian nation of Malaysia filed a police report targeting the Health Ministry for failing to use ivermectin to prevent COVID-19. In an unprecedented action, the Malaysia Muslim Consumers Association (PPIM) issued a statement declaring, “The Health Ministry’s refusal to consider the effectiveness of Ivermectin is a criminal offense as that has caused more than 2,300 COVID-19 patients to die.” https://trialsitenews.com/malaysian-activist-group-files-criminal-report-against-minister-of-health-for-keeping-ivermectin-from-the-people/

06-23-21 News Roundup | UK-based Meta Analysis On Ivermectin Peer Reviewed & Published UK-based Meta Analysis Peer Reviewed & Published Suggests Ivermectin A Key Public Health Weapon in the War Against COVID-19 Recently published in the peer-reviewed American Journal of Therapeutics, Dr. Tess Lawrie, an expert in medicinal evidence, along with other experts in population health and gastroenterology out of the United Kingdom (UK), conducted a comprehensive meta-analysis involving the certainty of evidence using an approach known as GRADE, which led to the focus on twenty-four ivermectin-centered randomized controlled trials involving 3,406 participants. https://trialsitenews.com/news-roundup-uk-based-meta-analysis-on-ivermectin-peer-reviewed-published/

06-23-21 University of Oxford PRINCIPLE Study Now Includes Ivermectin
https://trialsitenews.com/university-of-oxford-principle-study-now-includes-ivermectin/

06-23-21 Ivermectin for COVID-19: real-time meta analysis of 60 studies NOTE: There have been 60 completed Ivermectin studies (and numerous more are in progress) evidencing sufficient safety and efficacy. To date, these 60 studies involved: 18,931 patients and 549 investigators/scientists and represent stunning results.
85% improvement across 14 prophylaxis studies; 76% improvement in 25 early treatment trials; and 46% improvement in 21 late treatment trials along with 70% improvement in 22 mortality results. Of 31 randomized controlled trials: 64% show improvement. In addition, a prominent meta-analysis from the UK, published in the peer-review American Journal of Therapeutics, reveals that across 3,406 COVID-19 patients, Ivermectin led to a reduced risk of death, lowered infection, and even prophylactic benefits. https://ivmmeta.com/

06-24-21 Ivermectin Authorized in Indonesia as Pharma Issued License for Production to Battle COVID-19 The country’s national drug regulator authorized the use of ivermectin on an off-label basis targeting COVID-19. Based on the results of a study, … production now has commenced with plans for distribution of over 4 million units per month, declaring formally that ivermectin is now authorized as a therapy for COVID-19. https://trialsitenews.com/ivermectin-authorized-in-indonesia-as-pharma-issued-license-for-production-to-battle-covid-19/

07-08-21 NIH approves IVERMECTIN for use in treatment of COVID-19 – 78 studies in progress or completed showing efficacy https://www.covid19treatmentguidelines.nih.gov/tables/table-2e/

07-24-21 International Coalition of Medical Experts Tout the Effectiveness of IVERMECTIN https://www.theepochtimes.com/doctors-raise-awareness-on-ivermectin-as-treatment-for-covid-19-to-help-end-the-pandemic_3916366.html In an effort to help end the pandemic, an international coalition of medical experts held “World Ivermectin Day” to raise awareness about the effectiveness of ivermectin as a treatment for COVID-19.

07-28-21 Ivermectin for preventing and treating COVID-19 https://pubmed.ncbi.nlm.nih.gov/34318930/ Ivermectin, an antiparasitic agent used to treat parasitic infestations, inhibits the replication of viruses in vitro. The molecular hypothesis of ivermectin's antiviral mode of action suggests an inhibitory effect on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication in the early stages of infection.

07-31-21 White paper on Ivermectin as a potential therapy for COVID-19 https://pubmed.ncbi.nlm.nih.gov/32825892/ After critical panel discussion, all the attending doctors came to a conclusion that Ivermectin can be a potential molecule for prophylaxis and treatment of people infected with Coronavirus, owing to its anti-viral properties coupled with effective cost, availability and good tolerability and safety.

08-11-21 Potential use of ivermectin for the treatment and prophylaxis of SARS-CoV-2 infection https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354804/ “…Recently, promising results of several studies on oral ivermectin have been published, which has prompted us to conduct the present review of the scientific literature. The reviewed literature suggests that there seems to be sufficient evidence about the safety of oral ivermectin, as well as the efficacy of the drug in the early-treatment and the prophylaxis of COVID-19.”

09-17-21 El Salvador Minister of Public Health Includes Ivermectin as COVID-19 Pandemic Continues https://trialsitenews.com/el-salvador-minister-of-public-health-includes-ivermectin-as-covid-19-pandemic-continues/ El Salvador’s Ministry of Public Health (Ministerio de Salud Publica—MINSAL) embraced the anti-parasitic drug ivermectin as part of a combination of recommendations for early-onset treatment of COVID-19 via an ambulatory home patient kit which included vitamins and other therapeutics.

Ongoing https://clinicaltrials.gov/ 72 Studies found for: Ivermectin | Covid 23 Studies for Ivermectin | SARS-CoV-2 186 Studies for Ivermectin | entire Database